ADVERTISEMENT ADVERTISEMENT The real problem is not just how many people are on waiting lists, but how little
First, differences in design, individual characteristics, and follow-up duration among the included meta-analyses may contribute to heterogeneity in the results, particularly in the context of patients prior medication history
Harno E, Cottrell EC, Yu A et al (2013) 11beta-Hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors still improve metabolic phenotype in male 11beta-HSD1 knockout mice suggesting off-target mechanisms
Until FDA approval, our priority remains offering patients safe, effective, accessible weight-loss solutions that work today. Disclaimer: Dosage and pricing may vary based on medical evaluation
For some GLP-1 users, gastrointestinal issues like cramps or constipation can occur
Results Twenty-three trials enrolling a total number of 181,143 participants were included